These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis. Kamel Mohamed SG; Sugiyama E; Shinoda K; Hounoki H; Taki H; Maruyama M; Miyahara T; Kobayashi M Biochem Biophys Res Commun; 2005 Apr; 329(3):839-45. PubMed ID: 15752732 [TBL] [Abstract][Full Text] [Related]
3. Locally administered interferon-γ accelerates lipopolysaccharide-induced osteoclastogenesis independent of immunohistological RANKL upregulation. Ayon Haro ER; Ukai T; Yokoyama M; Kishimoto T; Yoshinaga Y; Hara Y J Periodontal Res; 2011 Jun; 46(3):361-73. PubMed ID: 21361961 [TBL] [Abstract][Full Text] [Related]
4. TNF Induction of NF-κB RelB Enhances RANKL-Induced Osteoclastogenesis by Promoting Inflammatory Macrophage Differentiation but also Limits It through Suppression of NFATc1 Expression. Zhao Z; Hou X; Yin X; Li Y; Duan R; Boyce BF; Yao Z PLoS One; 2015; 10(8):e0135728. PubMed ID: 26287732 [TBL] [Abstract][Full Text] [Related]
5. FTY720 inhibited proinflammatory cytokine release and osteoclastogenesis induced by Aggregatibacter actinomycetemcomitans. Yu H; Herbert BA; Valerio M; Yarborough L; Hsu LC; Argraves KM Lipids Health Dis; 2015 Jul; 14():66. PubMed ID: 26138336 [TBL] [Abstract][Full Text] [Related]
6. Overexpressed miR-145 inhibits osteoclastogenesis in RANKL-induced bone marrow-derived macrophages and ovariectomized mice by regulation of Smad3. Yu FY; Xie CQ; Sun JT; Peng W; Huang XW Life Sci; 2018 Jun; 202():11-20. PubMed ID: 29577879 [TBL] [Abstract][Full Text] [Related]
7. Reciprocal effects of Interferon-γ and IL-4 on differentiation to osteoclast-like cells by RANKL or LPS. Hu Y; Ek-Rylander B; Wendel M; Andersson G Oral Dis; 2014 Oct; 20(7):682-92. PubMed ID: 24118341 [TBL] [Abstract][Full Text] [Related]
8. Modulation of macrophage subtypes by IRF5 determines osteoclastogenic potential. Yang J; Park OJ; Kim J; Kwon Y; Yun CH; Han SH J Cell Physiol; 2019 Dec; 234(12):23033-23042. PubMed ID: 31127629 [TBL] [Abstract][Full Text] [Related]
9. Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis. Gong W; Dou H; Liu X; Sun L; Hou Y Clin Exp Pharmacol Physiol; 2012 Oct; 39(10):886-93. PubMed ID: 23013134 [TBL] [Abstract][Full Text] [Related]
10. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically. Valverde P; Tu Q; Chen J J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638 [TBL] [Abstract][Full Text] [Related]
11. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice. Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189 [TBL] [Abstract][Full Text] [Related]
12. A rapid multiparameter approach to study factors that regulate osteoclastogenesis: demonstration of the combinatorial dominant effects of TNF-alpha and TGF-ss in RANKL-mediated osteoclastogenesis. Huang W; Drissi MH; O'Keefe RJ; Schwarz EM Calcif Tissue Int; 2003 Dec; 73(6):584-93. PubMed ID: 14517717 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells. Mohamed SG; Sugiyama E; Shinoda K; Taki H; Hounoki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Ogawa H; Miyahara T Bone; 2007 Oct; 41(4):592-602. PubMed ID: 17627913 [TBL] [Abstract][Full Text] [Related]
15. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse. Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637 [TBL] [Abstract][Full Text] [Related]
16. Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease. Valverde P; Kawai T; Taubman MA J Bone Miner Res; 2004 Jan; 19(1):155-64. PubMed ID: 14753747 [TBL] [Abstract][Full Text] [Related]
17. Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 Activities. Joung YH; Darvin P; Kang DY; Sp N; Byun HJ; Lee CH; Lee HK; Yang YM PLoS One; 2016; 11(7):e0159891. PubMed ID: 27447722 [TBL] [Abstract][Full Text] [Related]
18. Alisol-B, a novel phyto-steroid, suppresses the RANKL-induced osteoclast formation and prevents bone loss in mice. Lee JW; Kobayashi Y; Nakamichi Y; Udagawa N; Takahashi N; Im NK; Seo HJ; Jeon WB; Yonezawa T; Cha BY; Woo JT Biochem Pharmacol; 2010 Aug; 80(3):352-61. PubMed ID: 20412788 [TBL] [Abstract][Full Text] [Related]
19. Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells. Kim JM; Lee JH; Lee GS; Noh EM; Song HK; Gu DR; Kim SC; Lee SH; Kwon KB; Lee YR BMC Complement Altern Med; 2017 Mar; 17(1):164. PubMed ID: 28335757 [TBL] [Abstract][Full Text] [Related]
20. Bach1 regulates osteoclastogenesis in a mouse model via both heme oxygenase 1-dependent and heme oxygenase 1-independent pathways. Hama M; Kirino Y; Takeno M; Takase K; Miyazaki T; Yoshimi R; Ueda A; Itoh-Nakadai A; Muto A; Igarashi K; Ishigatsubo Y Arthritis Rheum; 2012 May; 64(5):1518-28. PubMed ID: 22127667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]